Should Bone-Modifying Agents Be Used as Part of Adjuvant Therapy to Prevent Disease Recurrence?

CCO Slideset - Robert E. Coleman, MD, FRCP, provides updates and analyses of recent data on the use of bone-targeting agents in patients with breast cancer for the prevention of disease recurrence.
Source: Clinical Care Options Oncology - Breast Cancer - Category: Cancer & Oncology Source Type: research